These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23791978)

  • 1. Rosiglitazone-loaded nanospheres for modulating macrophage-specific inflammation in obesity.
    Di Mascolo D; J Lyon C; Aryal S; Ramirez MR; Wang J; Candeloro P; Guindani M; Hsueh WA; Decuzzi P
    J Control Release; 2013 Sep; 170(3):460-8. PubMed ID: 23791978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Sex on the Therapeutic Efficacy of Rosiglitazone in Modulating White Adipose Tissue Function and Insulin Sensitivity.
    Bauzá-Thorbrügge M; Amengual-Cladera E; Galmés-Pascual BM; Morán-Costoya A; Gianotti M; Valle A; Proenza AM; Lladó I
    Nutrients; 2024 Sep; 16(18):. PubMed ID: 39339665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of obesity-associated white adipose tissue inflammation by rosiglitazone is associated with reduced non-alcoholic fatty liver disease in LDLr-deficient mice.
    Mulder P; Morrison MC; Verschuren L; Liang W; van Bockel JH; Kooistra T; Wielinga PY; Kleemann R
    Sci Rep; 2016 Aug; 6():31542. PubMed ID: 27545964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARgamma activation attenuates T-lymphocyte-dependent inflammation of adipose tissue and development of insulin resistance in obese mice.
    Foryst-Ludwig A; Hartge M; Clemenz M; Sprang C; Hess K; Marx N; Unger T; Kintscher U
    Cardiovasc Diabetol; 2010 Oct; 9():64. PubMed ID: 20955583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced angiogenesis in obesity and in response to PPARgamma activators through adipocyte VEGF and ANGPTL4 production.
    Gealekman O; Burkart A; Chouinard M; Nicoloro SM; Straubhaar J; Corvera S
    Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1056-64. PubMed ID: 18728224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New PPARγ partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr(-/-) mice.
    Silva JC; César FA; de Oliveira EM; Turato WM; Tripodi GL; Castilho G; Machado-Lima A; de Las Heras B; Boscá L; Rabello MM; Hernandes MZ; Pitta MG; Pitta IR; Passarelli M; Rudnicki M; Abdalla DS
    Pharmacol Res; 2016 Feb; 104():49-60. PubMed ID: 26706782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid nanoparticles improve targeting to inflammatory macrophages through phagocytic signals.
    Bagalkot V; Badgeley MA; Kampfrath T; Deiuliis JA; Rajagopalan S; Maiseyeu A
    J Control Release; 2015 Nov; 217():243-55. PubMed ID: 26386437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPAR agonist-induced reduction of Mcp1 in atherosclerotic plaques of obese, insulin-resistant mice depends on adiponectin-induced Irak3 expression.
    Hulsmans M; Geeraert B; Arnould T; Tsatsanis C; Holvoet P
    PLoS One; 2013; 8(4):e62253. PubMed ID: 23620818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc deficiency alters lipid metabolism in LDL receptor deficient mice treated with rosiglitazone.
    Shen H; MacDonald R; Bruemmer D; Stromberg A; Daugherty A; Li XA; Toborek M; Hennig B
    J Nutr; 2007 Nov; 137(11):2339-45. PubMed ID: 17951467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fish oil decreases inflammation and reduces cardiac remodeling in rosiglitazone treated aging mice.
    Halade GV; Williams PJ; Lindsey ML; Fernandes G
    Pharmacol Res; 2011 Apr; 63(4):300-7. PubMed ID: 21193042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ursolic acid and rosiglitazone combination alleviates metabolic syndrome in high fat diet fed C57BL/6J mice.
    Sundaresan A; Harini R; Pugalendi KV
    Gen Physiol Biophys; 2012 Sep; 31(3):323-33. PubMed ID: 23047945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actions of PPARgamma agonism on adipose tissue remodeling, insulin sensitivity, and lipemia in absence of glucocorticoids.
    Berthiaume M; Sell H; Lalonde J; Gélinas Y; Tchernof A; Richard D; Deshaies Y
    Am J Physiol Regul Integr Comp Physiol; 2004 Nov; 287(5):R1116-23. PubMed ID: 15256367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of adipose tissues in the early hypolipidemic action of PPARgamma agonism in the rat.
    Laplante M; Festuccia WT; Soucy G; Gélinas Y; Lalonde J; Deshaies Y
    Am J Physiol Regul Integr Comp Physiol; 2007 Apr; 292(4):R1408-17. PubMed ID: 17170230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro-inflammatory cytokines negatively regulate PPARγ mediated gene expression in both human and murine macrophages via multiple mechanisms.
    Nagy ZS; Czimmerer Z; Szanto A; Nagy L
    Immunobiology; 2013 Nov; 218(11):1336-44. PubMed ID: 23870825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin-Loaded Polymeric Nanoparticles: Targeting Inflammatory Macrophages for Local Adipose Tissue Browning in Obesity Treatment.
    Mohaghegh N; Ahari A; Buttles C; Davani S; Hoang H; Huang Q; Huang Y; Hosseinpour B; Abbasgholizadeh R; Cottingham AL; Farhadi N; Akbari M; Kang H; Khademhosseini A; Jucaud V; Pearson RM; Hassani Najafabadi A
    ACS Nano; 2024 Oct; 18(40):27764-27781. PubMed ID: 39342648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone.
    Rong JX; Qiu Y; Hansen MK; Zhu L; Zhang V; Xie M; Okamoto Y; Mattie MD; Higashiyama H; Asano S; Strum JC; Ryan TE
    Diabetes; 2007 Jul; 56(7):1751-60. PubMed ID: 17456854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An M1-like Macrophage Polarization in Decidual Tissue during Spontaneous Preterm Labor That Is Attenuated by Rosiglitazone Treatment.
    Xu Y; Romero R; Miller D; Kadam L; Mial TN; Plazyo O; Garcia-Flores V; Hassan SS; Xu Z; Tarca AL; Drewlo S; Gomez-Lopez N
    J Immunol; 2016 Mar; 196(6):2476-2491. PubMed ID: 26889045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor gamma ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the -463GA promoter polymorphism.
    Kumar AP; Piedrafita FJ; Reynolds WF
    J Biol Chem; 2004 Feb; 279(9):8300-15. PubMed ID: 14668325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of alendronic- and undecylenic acid coated magnetic nanoparticles for the targeted delivery of rosiglitazone to subcutaneous adipose tissue.
    Saatchi K; Tod SE; Leung D; Nicholson KE; Andreu I; Buchwalder C; Schmitt V; Häfeli UO; Gray SL
    Nanomedicine; 2017 Feb; 13(2):559-568. PubMed ID: 27558352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic rosiglitazone treatment restores AMPKalpha2 activity in insulin-resistant rat skeletal muscle.
    Lessard SJ; Chen ZP; Watt MJ; Hashem M; Reid JJ; Febbraio MA; Kemp BE; Hawley JA
    Am J Physiol Endocrinol Metab; 2006 Feb; 290(2):E251-7. PubMed ID: 16118254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.